Institute: Massachusetts Institute of Technology and University of Nottingham
I’m currently an EPSRC E-TERM Fellow researching biomaterials for the control of immune cell behaviour, hosted by Nottingham University and MIT. Originally, I completed an MChem with a year in Industry at the University of York, and during my time there spent a year working in the Research and Development team at GSK as an organic chemist.
In 2010 I started a PhD at Imperial College London, focusing on nanomaterials for control of T cell activation, which I completed in early 2014. After this, I stayed at Imperial to complete an EPSRC Post-Doctoral Prize Fellowship focusing on nano-interfaces for immune cell behaviour, before taking on my current Fellowship at Nottingham in 2015.
My current focus is on applying biomaterials design to the control of immune cell behaviour within tissue engineering. I am interested in developing materials and devices to manage immune cell behaviour in the transplant niche, and localised immune cell therapies for chronic auto-immune disorders. .
My research focuses on immunoengineering within tissue engineering and regenerative medicine. I use biomaterials to direct immune cell behaviour, and nano- and microparticles to controllably deliver soluble and physical cues to specific cell populations as therapeutics in cancer and auto-immune disorders, and also in the transplant niche.
Human immune cell culture and differentiation
Localised in vivo delivery platforms
Nanoscale and microscale biomaterials synthesis
Biomaterials for control of cellular behaviour